Avanos Medical, Inc.
General ticker "AVNS" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $644.6M (TTM average)
Avanos Medical, Inc. follows the US Stock Market performance with the rate: 48.2%.
Estimated limits based on current volatility of 0.1%: low 24.91$, high 24.97$
Factors to consider:
- Total employees count: 2227 (-40.9%) as of 2024
- US accounted for 76.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Pandemic risks, Market competition, Supply chain disruptions, Economic downturns and volatility, Regulatory and compliance
- Current price 61.4% above estimated high
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.70$, 15.41$]
- 2026-12-31 to 2027-12-31 estimated range: [8.94$, 15.78$]
Financial Metrics affecting the AVNS estimates:
- Positive: with PPE of 12.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 14.03 > 12.90
- Negative: negative Net income
- Negative: negative Industry operating income (median)
- Positive: Industry inventory ratio change (median), % of -0.30 <= -0.16
- Negative: Investing cash flow per share per price, % of -11.38 <= -4.41
Short-term AVNS quotes
Long-term AVNS plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $673.30MM | $687.80MM | $701.20MM |
| Operating Expenses | $608.30MM | $647.80MM | $762.80MM |
| Operating Income | $65.00MM | $40.00MM | $-61.60MM |
| Non-Operating Income | $-72.90MM | $-443.30MM | $-4.60MM |
| Interest Expense | $15.00MM | $12.20MM | $4.00MM |
| R&D Expense | $27.20MM | $26.20MM | $23.10MM |
| Income(Loss) | $-7.90MM | $-403.30MM | $-66.20MM |
| Taxes | $2.00MM | $-17.00MM | $1.70MM |
| Other Income(Loss) | $-51.90MM | $0.00MM | $0.00MM |
| Net Income(Loss)* | $-61.80MM | $-392.10MM | $-62.90MM |
| Stockholders Equity | $1,236.30MM | $828.50MM | $778.20MM |
| Inventory | $163.20MM | $138.80MM | $148.00MM |
| Assets | $1,692.40MM | $1,154.20MM | $1,073.70MM |
| Operating Cash Flow | $32.40MM | $100.70MM | $74.70MM |
| Capital expenditure | $17.80MM | $17.80MM | $31.60MM |
| Investing Cash Flow | $21.60MM | $-27.50MM | $-60.60MM |
| Financing Cash Flow | $-94.20MM | $-49.10MM | $-37.00MM |
| Earnings Per Share** | $-1.33 | $-8.52 | $-1.36 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.